Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 004782
Company: WYETH PHARMS
Company: WYETH PHARMS
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| PREMARIN | ESTROGENS, CONJUGATED | 1.25MG | TABLET;ORAL | Prescription | AB | Yes | Yes |
| PREMARIN | ESTROGENS, CONJUGATED | 2.5MG | TABLET;ORAL | Discontinued | None | No | No |
| PREMARIN | ESTROGENS, CONJUGATED | 0.3MG | TABLET;ORAL | Prescription | AB | Yes | No |
| PREMARIN | ESTROGENS, CONJUGATED | 0.625MG | TABLET;ORAL | Prescription | AB | Yes | Yes |
| PREMARIN | ESTROGENS, CONJUGATED | 0.9MG | TABLET;ORAL | Prescription | AB | Yes | Yes |
| PREMARIN | ESTROGENS, CONJUGATED | 0.45MG | TABLET;ORAL | Prescription | AB | Yes | No |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 04/22/2025 | SUPPL-179 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/004782s179lbl.pdf | |
| 02/15/2024 | SUPPL-181 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/004782s181lbl.pdf | |
| 11/07/2017 | SUPPL-176 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/004782s176lbl.pdf | |
| 12/03/2014 | SUPPL-171 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/004782s171lbl.pdf | |
| 10/28/2011 | SUPPL-167 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/004782s162s164s167lbl.pdf | |
| 10/28/2011 | SUPPL-164 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/004782s162s164s167lbl.pdf | |
| 10/28/2011 | SUPPL-162 | Labeling-Patient Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/004782s162s164s167lbl.pdf | |
| 03/03/2008 | SUPPL-155 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/004782s155lbl.pdf | |
| 09/05/2006 | SUPPL-147 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/004782s147lbl.pdf | |
| 04/24/2006 | SUPPL-146 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/004782s146lbl.pdf | |
| 11/01/2005 | SUPPL-142 | Manufacturing (CMC)-Formulation | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/004782s142lbl.pdf | |
| 08/01/2005 | SUPPL-141 | Manufacturing (CMC)-Formulation | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/004782s141lbl.pdf | |
| 04/07/2005 | SUPPL-139 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/004782s138,139lbl.pdf | |
| 04/07/2005 | SUPPL-138 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/004782s138,139lbl.pdf | |
| 08/26/2004 | SUPPL-137 | Manufacturing (CMC)-Formulation | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/04782s137lbl.pdf | |
| 04/20/2004 | SUPPL-136 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/04782S136lbl.pdf | |
| 04/20/2004 | SUPPL-133 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/04782slr133,136_premarin_lbl.pdf | |
| 04/24/2003 | SUPPL-130 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/004782s115lbl.pdf | |
| 04/24/2003 | SUPPL-115 | Efficacy-New Dosing Regimen | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/004782s115lbl.pdf | |
| 01/07/2003 | SUPPL-129 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/04782s129lbl.pdf | |
| 11/27/2002 | SUPPL-128 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/04782slr128_Premarin_lbl.pdf |